Pharmacological effects of PTH1R agonists on jaw bone fracture, periodontitis, orthodontic treatment and MRONJ: a view from dosing regimen settings.

PTH1R agonists (teriparatide and abaloparatide) show potential in dental applications including jaw bone regeneration, orthodontics, and periodontitis treatment, but mandibular bone may require higher doses and longer treatment periods than other skeletal sites.

A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.